AtriCure Sells 5,000 Shares: Insider Move or Pattern Worth Watching?
A senior executive at AtriCure recently sold 5,000 shares, prompting questions about what this insider move means for...
Discover the importance of using asset allocation to balance risk and return. This strategy can enhance your investment performance.
28,655 articlesA senior executive at AtriCure recently sold 5,000 shares, prompting questions about what this insider move means for...
As AI transforms how businesses operate, one stock stands out as a potential long-term winner. This guide breaks down...
What can a legendary filmmaker teach you about money? This guide uses the idea behind steven spielberg says disclosur...
When a CEO unloads a big chunk of stock, investors take note. This article digs into sentinelone's sold over 39,000 s...
In a choppy 2026 market, Cathie Wood isn’t chasing high-flying tech alone. She’s quietly adding to positions in three...
Analysts map a path for UPS through 2026 and beyond, highlighting margin resilience, volume growth, and cost control ...
Cogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
A prominent investor dumped a multi‑million stake in a biotech stock that’s up double digits. This article explains w...
Analysts map a long-range path for SoFi Technologies, with a potential move into the upper 40s by 2030 as digital ban...
In March, oil price declines helped airline stocks rally even as the broader market parsed mixed signals. This articl...
Microsoft’s latest earnings show a resilient AI-powered expansion, with a $627 billion backlog and a near $37 billion...
Chewy’s stock action in May left investors asking what happened and what comes next. This article breaks down the cat...